Curie Capital
Venture capitalAmsterdam · Seed–Series A · 8 people tracked
Investment thesis
Curie Capital backs early-stage Life Sciences companies, investing at Seed and Series A stages in biotechnology, pharmaceutical, and medical technology firms typically focused on therapeutics, diagnostics, or class IIb and III medical devices. The firm typically leads rounds and syndicates alongside experienced co-investors, supporting portfolio companies with hands-on operational expertise and network access. Under its current fund (Curie Capital 3), it complies with RVO seed capital regulations and invests only in companies with a Dutch headquarters that have not raised more than €3.5 million in equity and/or convertible loans.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website & public directoriesWhat they invest in
from 3 of 7 portfolio companiesBiotech ×3Medical Devices ×2Healthtech ×1Longevity ×1
HQs:Netherlands×1
Investments · 7 tracked
founders shown can be your intro pathAllero Therapeutics develops non-invasive immunotherapies for immune-mediated disorders such as autoimmune and allergic diseases and anti-drug antibody (ADA) responses.
BiotechHealthtech
TargED Biopharmaceuticals is a Netherlands-based biotechnology company developing first-in-class biological drugs that use small antibodies (VHH) to deliver enzymes to sites of thrombosis for targeted thrombolysis.
BiotechMedical Devices
Frequently asked questions
- What stage does Curie Capital invest at?
- Curie Capital invests at the Seed, Series A stages.
- What sectors does Curie Capital focus on?
- Curie Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Curie Capital located?
- Curie Capital is headquartered in Amsterdam, NL.
- Does Curie Capital lead rounds?
- Yes, Curie Capital leads investment rounds.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Future Positive Capital's portfolio page showcasing companies across health, climate, and deeptech sectors.








